摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-苯基-1H-吡唑啉-1-基)哌啶 | 902836-40-2

中文名称
4-(4-苯基-1H-吡唑啉-1-基)哌啶
中文别名
——
英文名称
4-(4-phenyl-1H-pyrazol-1-yl)piperidine
英文别名
4-(4-phenylpyrazol-1-yl)piperidine
4-(4-苯基-1H-吡唑啉-1-基)哌啶化学式
CAS
902836-40-2
化学式
C14H17N3
mdl
MFCD08060998
分子量
227.3
InChiKey
SVKHSGABZPOEQY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.357
  • 拓扑面积:
    29.8
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • [EN] NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS 2-PIPERIDIN-1-YL-ACETAMIDE UTILISABLES EN TANT QU'INHIBITEURS DE TANKYRASE
    申请人:NOVARTIS AG
    公开号:WO2013012723A1
    公开(公告)日:2013-01-24
    The present invention provides for compounds of formula (I), wherein R1-R5 and L are defined herein. The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as for the use of such compounds as tankyrase inhibitors and in the treatment of Wnt signaling and tankyrase 1 and 2 signaling related disorders which include, but are not limited to, cancer.
    本发明提供了式(I)的化合物,其中R1-R5和L在此处定义。本发明还提供了包含式(I)化合物的药物组合物和组合物,以及将这些化合物用作坦基酶抑制剂以及用于治疗Wnt信号和坦基酶1和2信号相关疾病的用途,包括但不限于癌症。
  • [EN] ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN<br/>[FR] DÉRIVÉS D'ARYLCARBOXAMIDE EN TANT QU'INHIBITEURS DE CANAL SODIQUE POUR LE TRAITEMENT DE LA DOULEUR
    申请人:AMGEN INC
    公开号:WO2011103196A1
    公开(公告)日:2011-08-25
    The present invention provides compounds that are inhibitors of voltage-gated sodium channels (Nav), in particular Nav 1.7, and are therefore useful for the treatment of diseases treatable by inhibition of these channels, in particular, chronic pain disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
    本发明提供了一种抑制电压门控通道(Nav)的化合物,特别是Nav 1.7,因此适用于治疗通过抑制这些通道可治疗的疾病,特别是慢性疼痛疾病。还提供了含有这种化合物的药物组合物以及制备这种化合物的方法。
  • ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
    申请人:Li Xiaoming
    公开号:US20080194545A1
    公开(公告)日:2008-08-14
    The present invention is directed to compounds of formula I, pharmaceutical compositions comprising the compounds, and methods for making and using the inventive compounds.
    本发明涉及式I的化合物,包括该化合物的药物组合物,以及制备和使用该创新化合物的方法。
  • NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS
    申请人:Cheung Atwood Kim
    公开号:US20150025070A1
    公开(公告)日:2015-01-22
    The present invention provides for compounds of formula (I): wherein R 1 -R 5 and L are defined herein. The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as for the use of such compounds as tankyrase inhibitors and in the treatment of Wnt signaling and tankyrase 1 and 2 signaling related disorders which include, but are not limited to, cancer.
    本发明提供了公式(I)的化合物:其中R1-R5和L在此定义。本发明还提供了含有公式(I)化合物的药物组合物和组合物,以及将这些化合物用作坦克酶抑制剂和治疗与Wnt信号和坦克酶1和2信号相关的疾病的用途,包括但不限于癌症。
  • CARBOXAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS
    申请人:Bregman Howard
    公开号:US20130131035A1
    公开(公告)日:2013-05-23
    The present invention provides compounds that are inhibitors of voltage-gated sodium channels (Nav), in particular Nav 1.7, and are therefore useful for the treatment of diseases treatable by inhibition of these channels, in particular, chronic pain disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
    本发明提供了一种抑制电压门控通道(Nav)的化合物,特别是Nav 1.7,因此可用于治疗可通过抑制这些通道治疗的疾病,特别是慢性疼痛疾病。还提供了含有这种化合物的药物组合物以及制备这种化合物的方法。
查看更多